Crossref journal-article
Elsevier BV
The Journal of Steroid Biochemistry and Molecular Biology (78)
Bibliography

Vuorinen, A., Odermatt, A., & Schuster, D. (2013). In silico methods in the discovery of endocrine disrupting chemicals. The Journal of Steroid Biochemistry and Molecular Biology, 137, 18–26.

Authors 3
  1. Anna Vuorinen (first)
  2. Alex Odermatt (additional)
  3. Daniela Schuster (additional)
References 63 Referenced 47
  1. 10.1210/er.2009-0002 / Endocrine Reviews / Endocrine-disrupting chemicals: an endocrine society scientific statement by Diamanti-Kandarakis (2009)
  2. 10.1210/er.2011-1050 / Endocrine Reviews / Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses by Vandenberg (2012)
  3. 10.1111/j.1365-2605.2005.00561.x / International Journal of Andrology / Endocrine disrupters and human puberty by Den Hond (2006)
  4. 10.1093/toxsci/kfl051 / Toxicological Sciences / The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals by Sanderson (2006)
  5. 10.1111/j.1365-2605.2008.00899.x / International Journal of Andrology / Is hypospadias a genetic, endocrine or environmental disease, or still an unexplained malformation? by Kalfa (2009)
  6. 10.3390/molecules16129983 / Molecules / Inhibitors of testosterone biosynthetic and metabolic activation enzymes by Ye (2011)
  7. 10.1016/j.cbi.2011.12.008 / Chemico-Biological Interactions / Effects of phthalates on 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase 3 activities in human and rat testes by Yuan (2012)
  8. 10.1016/j.jsbmb.2006.09.010 / Journal of Steroid Biochemistry and Molecular Biology / Disruption of glucocorticoid action by environmental chemicals: potential mechanisms and relevance by Odermatt (2006)
  9. 10.1016/j.bcp.2008.07.019 / Biochemical Pharmacology / Glucocorticoid and mineralocorticoid action: why should we consider influences by environmental chemicals? by Odermatt (2008)
  10. 10.1016/j.toxlet.2012.10.002 / Toxicology letters / Inhibition of human and rat 11beta-hydroxysteroid dehydrogenases activities by bisphenol A by Guo (2012)
  11. {'key': '10.1016/j.jsbmb.2013.04.009_bib0055', 'first-page': '52', 'article-title': 'Endocrine-disrupting chemicals: associated disorders and mechanisms of action', 'author': 'De Coster', 'year': '2012', 'journal-title': 'Journal of Environment and Public Health'} / Journal of Environment and Public Health / Endocrine-disrupting chemicals: associated disorders and mechanisms of action by De Coster (2012)
  12. 10.1186/1476-069X-11-S1-S8 / Environmental Health / Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney, pancreas, and brain by Fucic (2012)
  13. {'issue': '74–82', 'key': '10.1016/j.jsbmb.2013.04.009_bib0065', 'article-title': 'Disruption of androgen receptor signaling in males by environmental chemicals', 'volume': '127', 'author': 'Luccio-Camelo', 'year': '2011', 'journal-title': 'The Journal of Steroid Biochemistry and Molecular Biology'} / The Journal of Steroid Biochemistry and Molecular Biology / Disruption of androgen receptor signaling in males by environmental chemicals by Luccio-Camelo (2011)
  14. 10.1677/joe.0.1580327 / Journal of Endocrinology / Several environmental oestrogens are also anti-androgens by Sohoni (1998)
  15. 10.1016/j.mce.2009.02.017 / Molecular and Cellular Endocrinology / PPAR-mediated activity of phthalates: a link to the obesity epidemic? by Desvergne (2009)
  16. 10.1042/BSR20120042 / Bioscience Reports / The endocrine disruptor monoethyl-hexyl-phthalate promotes adipocyte differentiation and induces obesity in mice by Hao (2012)
  17. {'key': '10.1016/j.jsbmb.2013.04.009_bib0085', 'first-page': '144', 'article-title': 'Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behavious and neuroendocrine systems', 'volume': '24', 'author': 'Frye', 'year': '2011', 'journal-title': 'Journal of Endocrinology'} / Journal of Endocrinology / Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behavious and neuroendocrine systems by Frye (2011)
  18. 10.1210/endo.138.3.4979 / Endocrinology / Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta by Kuiper (1997)
  19. 10.1371/journal.pone.0031109 / PLoS One / Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor beta by Soriano (2012)
  20. 10.1073/pnas.1203574109 / Proceedings of the National Academy of Sciences of the United States of America / Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes by Delfosse (2012)
  21. 10.1016/j.toxlet.2006.11.016 / Toxicology Letters / Estrogens and antiestrogens activate hPXR by Mnif (2007)
  22. 10.1289/ehp.1104426 / Environmental Health Perspectives / Bisphenol A and its analogues activate human pregnane X receptor by Sui (2012)
  23. 10.1289/ehp.1003328 / Environmental Health Perspectives / Peroxisome proliferator-activated receptor gamma is a target for halogenated analogs of bisphenol A by Riu (2011)
  24. 10.1093/toxsci/kfr132 / Toxicological Sciences / Characterization of novel ligands of ERalpha, ERbeta, and PPARgamma: the case of halogenated bisphenol A and their conjugated metabolites by Riu (2011)
  25. 10.1093/toxsci/kfr312 / Toxicological Sciences / Parallel biotransformation of tetrabromobisphenol A in Xenopus laevis and mammals: Xenopus as a model for endocrine perturbation studies by Fini (2012)
  26. 10.1210/jc.2002-020209 / Journal of Clinical Endocrinology and Metabolism / Thyroid hormone action is disrupted by bisphenol A as an antagonist by Moriyama (2002)
  27. 10.1210/me.2010-0284 / Molecular Endocrinology / Minireview: extranuclear steroid receptors: roles in modulation of cell functions by Levin (2011)
  28. 10.1016/j.mce.2003.09.027 / Molecular and Cellular Endocrinology / A rapid screening assay for inhibitors of 11beta-hydroxysteroid dehydrogenases (11beta-HSD): flavanone selectively inhibits 11beta-HSD1 reductase activity by Schweizer (2003)
  29. 10.1016/j.toxlet.2011.09.001 / Toxicology letters / Inhibition of human and rat testicular steroidogenic enzyme activities by bisphenol A by Ye (2011)
  30. {'key': '10.1016/j.jsbmb.2013.04.009_bib0150', 'first-page': '1', 'article-title': 'The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydyroxysteroid dehydrogenase type 1 in the adipose tissue of children', 'author': 'Wang', 'year': '2012', 'journal-title': 'International Journal of Obesity'} / International Journal of Obesity / The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydyroxysteroid dehydrogenase type 1 in the adipose tissue of children by Wang (2012)
  31. 10.1095/biolreprod.111.095349 / Biology of Reproduction / The industrial chemical Bisphenol A (BPA) interferes with proliferative activity and development of steroidogenic capacity in rat Leydig cells by Nanjappa (2012)
  32. {'key': '10.1016/j.jsbmb.2013.04.009_bib0160', 'article-title': 'The holistic integration of virtual screening in drug discovery', 'volume': '00', 'author': 'Tanrikulu', 'year': '2013', 'journal-title': 'Drug Discovery Today'} / Drug Discovery Today / The holistic integration of virtual screening in drug discovery by Tanrikulu (2013)
  33. 10.1021/jm010548w / Journal of Medicinal Chemistry / Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B by Doman (2002)
  34. 10.1016/j.bmc.2010.05.071 / Bioorganic & Medicinal Chemistry / Morphinans and isoquinolines: acetylcholinesterase inhibition, pharmacophore modeling, and interaction with opioid receptors by Schuster (2010)
  35. 10.1351/pac199870051129 / Pure & Applied Chemistrty / Glossary of terms used in medicinal chemistry (IUPAC recommendations) by Wermuth (1998)
  36. 10.1016/0958-1669(95)80107-3 / Current Opinion in Biotechnology / Docking small-molecule ligands into active sites by Jones (1995)
  37. 10.1021/jm040163o / Journal of Medicinal Chemistry / A shape-based 3-D Scaffold Hopping method and its application to a bacterial protein–protein interaction by Rush (2005)
  38. 10.1038/sj.bjp.0707305 / British Journal of Pharmacology / In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling by Ekins (2007)
  39. 10.1038/nbt1284 / Nature Biotechnology / Relating protein pharmacology by ligand chemistry by Keiser (2007)
  40. 10.1080/10629360601054032 / SAR and QSAR in Environmental Research / PASS: identification of probable targets and mechanisms of toxicity by Poroikov (2007)
  41. 10.1016/j.jsbmb.2010.12.013 / The Journal of Steroid Biochemistry and Molecular Biology / 17b-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development by Marchais-Oberwinkler (2011)
  42. 10.1016/j.bcp.2009.12.005 / Biochemical Pharmacology / The UV-filter benzophenone-1 inhibits 17β-hydroxysteroid dehydrogenase type 3: virtual screening as a strategy to identify potential endocrine disrupting chemicals by Nashev (2010)
  43. 10.1371/journal.pone.0046958 / PLoS One / Virtual screening as a strategy for the identification of xenobiotics disrupting corticosteroid action by Nashev (2012)
  44. 10.1021/jm0600794 / Journal of Medicinal Chemistry / The discovery of new 11β-hydroxysteroid dehydrogenase Type 1 inhibitors by common feature pharmacophore modeling and virtual screening by Schuster (2006)
  45. 10.1021/tx0601509 / Chemical Research in Toxicology / QSAR prediction of estrogen activity for a large set of diverse chemicals under the guidance of OECD principles by Liu (2006)
  46. 10.1021/ci100078u / Journal of Chemical Information and Modeling / Classification and virtual screening of androgen receptor antagonists by Li (2010)
  47. 10.14573/altex.2009.3.167 / Altex / VirtualToxLab – in silico prediction of the toxic (endocrine-disrupting) potential of drugs, chemicals and natural products. Two years and 2,000 compounds of experience: a progress report by Vedani (2009)
  48. 10.1021/tx060218k / Chemical Research in Toxicology / Identification of previously unrecognized antiestrogenic chemicals using a novel virtual screening approach by Wang (2006)
  49. 10.1023/A:1025361621494 / Journal of Computer Aided Molecular Designing / In silico prediciton of drug toxicity by Dearden (2003)
  50. 10.2174/157016306776637609 / Current Drug Discovery Technologies / Development and validation of an in silico p450 profiler based on pharmacophore models by Schuster (2006)
  51. 10.1021/jm900817u / Journal of Medicinal Chemistry / Three-dimensional pharmacophore methods in drug discovery by Leach (2010)
  52. 10.1016/j.jmgm.2008.01.002 / Journal of Molecular Graphics and Modelling / The importance of the domain of applicability in QSAR modeling by Weaver (2008)
  53. 10.1016/j.ddtec.2010.12.003 / Current Drug Discovery Technologies / Docking compared to 3D-pharmacophores: the scoring function challenge by Hein (2010)
  54. 10.1016/S0006-291X(03)01359-7 / Biochemical and Biophysical Research Communications / Inhibition of 11β-hydroxysteroid dehydrogenase type 2 by dithiocarbamates by Atanasov (2003)
  55. 10.1016/j.tox.2012.07.001 / Toxicology / Species-specific differences in the inhibition of human and zebrafish 11beta-hydroxysteroid dehydrogenase 2 by thiram and organotins by Meyer (2012)
  56. 10.1371/journal.pone.0003545 / PLoS ONE / Dibutyltin disrupts glucocorticoid receptor function and impairs glucocorticoid-induced suppression of cytokine production by Gumy (2008)
  57. 10.1002/qsar.19960150405 / Quantitative Structure-activity Relationships / Quantum-chemical descriptors for estimating the acute toxicity of electrophiles to the fathed minnow (Pimephales promelas): an analysis based on molecular mechanisms by Karabunarliev (1996)
  58. 10.1021/jm301008n / Journal of Medicinal Chemistry / Rules for identifying potentially reactive or promiscuos compounds by Bruns (2012)
  59. 10.1021/ci300196g / Journal of Chemical Information and Modeling / Structural insights into the molecular basis of the ligand promiscuity by Sturm (2012)
  60. 10.1021/ci100136b / Journal of Chemical Information and Modeling / One concept, three implementations of 3D pharmacophore-based virtual screening: distinct coverage of chemical search space by Spitzer (2010)
  61. 10.1371/journal.pone.0011955 / PLoS One / Virtual screening for HIV protease inhibitors: a comparison of AutoDock4 and Vina by Chang (2010)
  62. 10.2174/0929867003375317 / Current Medicinal Chemistry / Molecular modeling and computer aided drug design. Examples of their application in medicinal chemistry by Ooms (2000)
  63. 10.1517/13543776.2010.505604 / Expert Opinion on Therapeutic Patents / 17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review by Poirier (2010)
Dates
Type When
Created 12 years, 3 months ago (May 17, 2013, 3:01 p.m.)
Deposited 6 years, 1 month ago (July 13, 2019, 3 p.m.)
Indexed 5 hours, 15 minutes ago (Aug. 27, 2025, 12:29 p.m.)
Issued 11 years, 11 months ago (Sept. 1, 2013)
Published 11 years, 11 months ago (Sept. 1, 2013)
Published Print 11 years, 11 months ago (Sept. 1, 2013)
Funders 0

None

@article{Vuorinen_2013, title={In silico methods in the discovery of endocrine disrupting chemicals}, volume={137}, ISSN={0960-0760}, url={http://dx.doi.org/10.1016/j.jsbmb.2013.04.009}, DOI={10.1016/j.jsbmb.2013.04.009}, journal={The Journal of Steroid Biochemistry and Molecular Biology}, publisher={Elsevier BV}, author={Vuorinen, Anna and Odermatt, Alex and Schuster, Daniela}, year={2013}, month=sep, pages={18–26} }